Published by Pharmafocus, authored by Will Maier, Chief Scientific Officer, Head of Rare Disease Research, ICON Commercialization and Outcomes, this article explores the cost challenges presented by precision medicine in rare disease and the strategies that can be employed to overcome them.

Rare and orphan diseases insights

ICON's Rare and Orphan Diseases team provides analysis including whitepapers, blogs and contributions to media and industry conversations relating to all aspects of rare and orphan diseases in clinical trials.

Read more